SCHEMBL16454352

SCHEMBL16454352

Cc1ccc(N(C)C(=O)C(C)(C)C)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
NOTUM Q6P988 2/20 0.37
KMT2A Q03164 3/20 0.36
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
MEN1 O00255 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ATM Q13315 1/20 0.35
NPY2R P49146 1/20 0.34
HSD17B10 Q99714 3/20 0.34
NPSR1 Q6W5P4 1/20 0.34
OXTR P30559 1/20 0.34
SLC22A12 Q96S37 1/20 0.34
TSHR P16473 1/20 0.34
CYP1A2 P05177 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
GRM5 P41594 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17816225 0.81 NOTUM (0.36) NOTUMKMT2ACYP3A4CYP2C9CYP2C19
SCHEMBL21592981 0.80 ALDH1A1 (0.45) HDAC1HDAC6KMT2ASMN1; SMN2HSD17B10
SCHEMBL7733716 0.79 NOTUM (0.52) NOTUMKMT2ACYP3A4CYP2C9CYP2C19
SCHEMBL20038047 0.79 KMT2A (0.42) HDAC1HDAC6KMT2ACYP3A4CYP2C9
SCHEMBL30937169 0.79 HDAC1 (0.41) HDAC1HDAC6NOTUMKMT2ACYP3A4
SCHEMBL14337547 0.75 NOTUM (0.41) HDAC1HDAC6NOTUMCYP3A4CYP2C9
SCHEMBL20038124 0.75 NOTUM (0.41) HDAC1HDAC6NOTUMCYP2C19SMN1; SMN2
SCHEMBL16446650 0.75 KMT2A (0.38) NOTUMKMT2ACYP3A4CYP2C9CYP2C19
SCHEMBL2241922 0.72 HDAC1 (0.42) HDAC1HDAC6KMT2ASMN1; SMN2ATM
SCHEMBL17565545 0.72 HDAC1 (0.36) HDAC1HDAC6KMT2ACYP2C19ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019238067-A1 PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF BEIGENE, LTD. (KY) 2019-12-19 WO disclosed
EP-3030081-B1 PYRAZOLYL PYRROLINONES AND THEIR USE AS HERBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2017-08-02 EP disclosed
US-20160159781-A1 CHEMICAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 US disclosed
WO-2015018431-A1 PYRAZOLYL PYRROLINONES AND THEIR USE AS HERBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2015-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160159781-A1 CHEMICAL COMPOUNDS DDT, CBR3, CYP1B1 HDAC1 1858/4885HDAC6 3520/4885NOTUM 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.